Impact of epoetin beta on quality of life in patients with malignant disease.

Br J Cancer · 2003 · PMC2376376 · PMID 12671693

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

a trend towards significanceP =0.076so close (0.05 < p ≤ 0.1)

Using LOCF data ( n =104 epoetin β , n =109 control), the median changes (baseline to final visit) for the SF-36 PCS (+3.1 points) and FACT-F (+3.0 points) scores were significantly different from those in the control group ( P <0.05), and a trend towards significance was apparent with respect to the change in the FACT-An subscale score (+1.0 points) ( P =0.076).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.